Compare Salesforce Inc (CRM) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Cronos Group Inc — how do they compare? Salesforce Inc trades at $169.17 (market cap $137.23B), while Cronos Group Inc trades at $2.74 (market cap $1.02B). The key difference: Salesforce Inc is far larger — about 134.5× Cronos Group Inc's market cap, and Salesforce Inc pays a 1.05% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRM | CRON | |
|---|---|---|
Market Cap | $137.23B | $1.02B |
Sector | Technology | Health |
52-Week High | $270.25 | $3.27 |
52-Week Low | $150.12 | $1.95 |
Enterprise Value | $167.28B | $203.29M |
Dividend Yield | 1.05% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $171.22, up 4.84% over 24 hours, with a bullish technical signal despite mixed momentum indicators. The company demonstrates strong fundamentals, including a 77.64% gross margin and consistent earnings beats, with Q1 2026 EPS of $3.88 exceeding the $3.13 estimate. Revenue grew to $37.90B in 2025, and operating cash flow reached $13.09B. Recent news highlights AI-driven growth potential, though the stock faces sector-wide volatility.
Outlook remains positive with a consensus price target of $235.90, implying 38% upside, supported by 73 buy ratings. Risks include competitive pressures in SaaS and macroeconomic sensitivity. AI adoption and strong cash flow generation present key opportunities for long-term investors.
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
